FIELD: medicine, pediatrics.
SUBSTANCE: invention concerns the prediction of the risk of development or progression of chronic kidney disease (CKD) in children with a typical form of hemolytic-uremic syndrome (stec-HUS). The method includes taking blood, determining the level of serotonin 5-HT in blood plasma and blood plasma enriched with platelets, determining the level of 5-hydroxyindoleacetic acid (5-HIAA) in blood plasma in a patient with a typical form of hemolytic uremic syndrome and determining the risk of developing CKD in children with stec-HUS according to the formula. If a value is greater than or equal to 0.577 in children with a typical form of hemolytic uremic syndrome, a high risk of developing CKD or progression of chronic kidney disease is predicted.
EFFECT: invention provides a reliable prediction of the risk of developing chronic kidney disease in children with hemolytic-uremic syndrome at an early stage of the development of the disease and, accordingly, the possibility of timely nephroprotective therapy in order to prevent the progression of CKD.
2 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR PREDICTING TUBULO-INTERSTITIAL KIDNEY DISEASE IN CHILDREN ASSOCIATED WITH HEMOLYTIC-UREMIC SYNDROME | 2021 |
|
RU2782125C1 |
METHOD OF PREDICTING THE SEVERITY OF HEMOLYTIC UREMIC SYNDROME IN CHILDREN WITH INFECTIOUS DISEASES | 2022 |
|
RU2797122C1 |
METHOD FOR DIAGNOSING EARLY CHRONIC RENAL DISEASE IN CHILDREN | 2020 |
|
RU2753581C1 |
METHOD OF ASSESSING EFFECTIVENESS OF NEPHROPROTECTIVE THERAPY IN HYPERTENSIVE PATIENTS WITH STAGE C2 CHRONIC KIDNEY DISEASE | 2023 |
|
RU2810453C1 |
METHOD FOR TREATMENT OF PATIENTS WITH CHRONIC KIDNEY DISEASE C3-C5 AT DIALYSIS STAGE, EXCLUDING PYELONEPHRITIS, UROLITHIASIS | 2017 |
|
RU2646467C1 |
METHOD OF PREDICTING CHARACTER OF PROGRESSING COURSE OF CHRONIC KIDNEY DISEASE | 2010 |
|
RU2430364C1 |
DIAGNOSTIC TECHNIQUE FOR STAGES OF CHRONIC KIDNEY DISEASE | 2013 |
|
RU2565394C2 |
EARLY DIAGNOSTIC TECHNIQUE FOR CHRONIC RENAL DISEASE | 2013 |
|
RU2566709C2 |
METHOD FOR DIAGNOSING SECONDARY NEPHROPATHIES IN RHEUMATIC DISEASES IN CHILDREN | 2023 |
|
RU2824052C1 |
METHOD FOR DIAGNOSTICS OF PROTEIN-ENERGY INSUFFICIENCY IN ADULT PATIENTS WITH STAGE 3A-5D CHRONIC KIDNEY DISEASE | 2021 |
|
RU2770551C1 |
Authors
Dates
2023-06-07—Published
2022-10-04—Filed